AstraZeneca loses German court appeal over Seroquel XR drug patent

January 13, 2015 5:08 PM

4 0

AstraZeneca loses German court appeal over Seroquel XR drug patent

KARLSRUHE, Germany (Reuters) - Britain's AstraZeneca Plc on Tuesday lost an appeal in Germany's Federal Court against generic drugmakers selling cheap copies of its anti-psychotic drug Seroquel XR.

In November 2012, the federal patent court in Germany ruled a key patent on Seroquel XR, the extended-release version of Seroquel, was invalid.

Read more

To category page

Loading...